Read More Pharma Industry News Gilead to acquire stake in cancer immunotherapy company Pionyr Immunotherapeutics Gilead Sciences has agreed to acquire a stake of 49.9% in California-based cancer immunotherapy company Pionyr Immunotherapeutics, for… bypharmanewsdailyJune 25, 2020
